Conflict of interest: B. C. has received speaker's honoraria from Novartis and Boehringer Ingelheim and has consulted for Lundbeck. S. D. has served on advisory boards or given lectures for Boehringer Ingelheim, Pfizer, and Sanofi Aventis. R. B. and G. W. A. have equity interest in iSchemaView. G. W. A. has served on advisory boards for Genentech and Lundbeck. All other authors report no conflict of interest.
Patients with single distal MCA perfusion lesions have a high rate of good outcome with or without reperfusion
Article first published online: 23 DEC 2013
© 2013 The Authors. International Journal of Stroke © 2013 World Stroke Organization
International Journal of Stroke
Volume 9, Issue 2, pages 156–159, February 2014
How to Cite
Lemmens, R., Christensen, S., Straka, M., De Silva, D. A., Mlynash, M., Campbell, B. C. V., Bammer, R., Olivot, J.-M., Desmond, P., Marks, M. P., Davis, S. M., Donnan, G. A., Albers, G. W. and Lansberg, M. G. (2014), Patients with single distal MCA perfusion lesions have a high rate of good outcome with or without reperfusion. International Journal of Stroke, 9: 156–159. doi: 10.1111/ijs.12230
Funding: The DEFUSE study was supported by the National Institutes of Health (NINDS, RO1 NS39325; K24 NS044848). The EPITHET study was supported by National Health and Medical Research Council, Australia; National Stroke Foundation, Australia; Heart Foundation of Australia. The DEFUSE 2 study was supported by the National Institutes of Health (NINDS, K23 NS051372; R01 NS03932505). R. L. is a senior clinical investigator of FWO Flanders.
- Issue published online: 20 JAN 2014
- Article first published online: 23 DEC 2013
- National Institutes of Health. Grant Numbers: RO1 NS39325, K24 NS044848, K23 NS051372, R01 NS03932505
- National Health and Medical Research Council, Australia
- National Stroke Foundation, Australia
- Heart Foundation of Australia
- distal MCA;
- functional outcome;
- perfusion imaging;
Reperfusion is associated with good functional outcome after stroke. However, minimal data are available regarding the effect of reperfusion on clinical outcome and infarct growth in patients with distal MCA branch occlusions.
The aim of this study was to evaluate this association and to determine the impact of the perfusion-diffusion mismatch.
Individual patient data from three stroke studies (EPITHET, DEFUSE and DEFUSE 2) with baseline MRI profiles and reperfusion status were pooled. Patients were included if they had a single cortical perfusion lesion on their baseline MRI that was consistent with a distal MCA branch occlusion. Good functional outcome was defined as a score of 0–2 on the modified Rankin Scale at day 90 and infarct growth was defined as change in lesion volume between the baseline DWI and the final T2/FLAIR.
Thirty patients met inclusion criteria. Eighteen (60%) had a good functional outcome and twenty (67%) had reperfusion. Reperfusion was not associated with good functional outcome in the overall cohort (OR: 1·0, 95% CI 0·2–4·7) and also not in the subset of patients with a PWI-DWI mismatch (n = 17; OR: 0·7, 95% CI 0·1–5·5). Median infarct growth was modest and not significantly different between patients with (0 ml) and without reperfusion (6 ml); P = 0·2.
The overall high rate of good outcomes in patients with distal MCA perfusion lesions might obscure a potential benefit from reperfusion in this population. A larger pooled analysis evaluating the effect of reperfusion in patients with distal MCA branch occlusions is warranted as confirmation of our results could have implications for the design of future stroke trials.